NEUROLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1190321, encodeId=f08a1190321a8, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：genetics;neurology 经验分享：来来回回半年，最后accept了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1413, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Sat Feb 05 14:56:21 CST 2022, time=2022-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953361, encodeId=831e9533619d, content=审稿速度:1.0 偏重的研究方向：AD 经验分享：速度很快，正常大修，不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=946, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=229a5412742, createdName=nmbwcnm, createdTime=Fri Apr 02 19:49:10 CST 2021, time=2021-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189031, encodeId=0aad11890319a, content=投稿一个月后送外审，外审一个半月被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1110, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acb95582948, createdName=ms1000001317492201, createdTime=Sat Jan 29 09:31:48 CST 2022, time=2022-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058443, encodeId=970d105844349, content=偏重的研究方向：神经病理 经验分享：投了一个神经罕见疾病病理方面的稿子，等待中........., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=909, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200528/5dca394cc76f4f16aef355c4dc927622/f9d77939380002a9e1bf3cc072db4be6_1_3_photo.jpg, createdBy=23ff2009942, createdName=1e1e9780m37(暂无匿称), createdTime=Thu Oct 07 20:08:15 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192132, encodeId=cd971192132ad, content=偏重的研究方向：神经系统疾病;Genetics 经验分享：多活动手脚, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=296a6497387, createdName=ms2000001939126778, createdTime=Fri Feb 11 00:26:21 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188425, encodeId=ec3e1188425ae, content=12月22号投稿，1月26号被拒，中间没有任何状态变化。 拒稿信如下，一同拒绝了我转投他家其他杂志。 If you had approved a lateral transfer to one of the other Neurology Journals (Neurology: Clinical Practice, Neurology: Genetics, or Neurology: Neuroimmunology & Neuroinflammation) the decision to reject also applies to these other journals. 投的生信方面的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=854, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a1de5106745, createdName=146070f9m77(暂无昵称), createdTime=Wed Jan 26 22:16:32 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181053, encodeId=a3f3118105365, content=2021年11月2日投稿，2021年12月7日收到送外审邮件，目前还在under review中！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1295, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=63101979945, createdName=美景, createdTime=Wed Jan 05 21:29:54 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095455, encodeId=5127109545591, content=文章题目有没有撰写模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095456, encodeId=18d51095456a4, content=什么样的题目能让审稿人眼前一亮？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=977, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601459, encodeId=60d060145923, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：Cognitive impairment 经验分享：硕士二年级，Lancet neurology投稿拒稿后转投neurology，审稿一个月后，三个审稿人一直positive，前两个提个两个不算问题的意见，第三个直接说没问题，杂志给的小修，稍微update了一下数据投出后13天直接接收。个人觉得审稿时间在10分以下算很快的了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30a72473112, createdName=肥肥猫目标发lancet, createdTime=Fri Jun 05 01:49:19 CST 2020, time=2020-06-05, status=1, ipAttribution=)]

2022-02-05 12588598m48暂无昵称

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：genetics;neurology
经验分享：来来回回半年，最后accept了

1413 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=1190321, encodeId=f08a1190321a8, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：genetics;neurology 经验分享：来来回回半年，最后accept了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1413, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Sat Feb 05 14:56:21 CST 2022, time=2022-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953361, encodeId=831e9533619d, content=审稿速度:1.0 偏重的研究方向：AD 经验分享：速度很快，正常大修，不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=946, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=229a5412742, createdName=nmbwcnm, createdTime=Fri Apr 02 19:49:10 CST 2021, time=2021-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189031, encodeId=0aad11890319a, content=投稿一个月后送外审，外审一个半月被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1110, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acb95582948, createdName=ms1000001317492201, createdTime=Sat Jan 29 09:31:48 CST 2022, time=2022-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058443, encodeId=970d105844349, content=偏重的研究方向：神经病理 经验分享：投了一个神经罕见疾病病理方面的稿子，等待中........., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=909, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200528/5dca394cc76f4f16aef355c4dc927622/f9d77939380002a9e1bf3cc072db4be6_1_3_photo.jpg, createdBy=23ff2009942, createdName=1e1e9780m37(暂无匿称), createdTime=Thu Oct 07 20:08:15 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192132, encodeId=cd971192132ad, content=偏重的研究方向：神经系统疾病;Genetics 经验分享：多活动手脚, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=296a6497387, createdName=ms2000001939126778, createdTime=Fri Feb 11 00:26:21 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188425, encodeId=ec3e1188425ae, content=12月22号投稿，1月26号被拒，中间没有任何状态变化。 拒稿信如下，一同拒绝了我转投他家其他杂志。 If you had approved a lateral transfer to one of the other Neurology Journals (Neurology: Clinical Practice, Neurology: Genetics, or Neurology: Neuroimmunology & Neuroinflammation) the decision to reject also applies to these other journals. 投的生信方面的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=854, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a1de5106745, createdName=146070f9m77(暂无昵称), createdTime=Wed Jan 26 22:16:32 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181053, encodeId=a3f3118105365, content=2021年11月2日投稿，2021年12月7日收到送外审邮件，目前还在under review中！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1295, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=63101979945, createdName=美景, createdTime=Wed Jan 05 21:29:54 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095455, encodeId=5127109545591, content=文章题目有没有撰写模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095456, encodeId=18d51095456a4, content=什么样的题目能让审稿人眼前一亮？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=977, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601459, encodeId=60d060145923, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：Cognitive impairment 经验分享：硕士二年级，Lancet neurology投稿拒稿后转投neurology，审稿一个月后，三个审稿人一直positive，前两个提个两个不算问题的意见，第三个直接说没问题，杂志给的小修，稍微update了一下数据投出后13天直接接收。个人觉得审稿时间在10分以下算很快的了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30a72473112, createdName=肥肥猫目标发lancet, createdTime=Fri Jun 05 01:49:19 CST 2020, time=2020-06-05, status=1, ipAttribution=)]

2021-04-02 nmbwcnm

审稿速度:1.0
偏重的研究方向：AD
经验分享：速度很快，正常大修，不错

946 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1190321, encodeId=f08a1190321a8, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：genetics;neurology 经验分享：来来回回半年，最后accept了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1413, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Sat Feb 05 14:56:21 CST 2022, time=2022-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953361, encodeId=831e9533619d, content=审稿速度:1.0 偏重的研究方向：AD 经验分享：速度很快，正常大修，不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=946, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=229a5412742, createdName=nmbwcnm, createdTime=Fri Apr 02 19:49:10 CST 2021, time=2021-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189031, encodeId=0aad11890319a, content=投稿一个月后送外审，外审一个半月被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1110, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acb95582948, createdName=ms1000001317492201, createdTime=Sat Jan 29 09:31:48 CST 2022, time=2022-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058443, encodeId=970d105844349, content=偏重的研究方向：神经病理 经验分享：投了一个神经罕见疾病病理方面的稿子，等待中........., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=909, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200528/5dca394cc76f4f16aef355c4dc927622/f9d77939380002a9e1bf3cc072db4be6_1_3_photo.jpg, createdBy=23ff2009942, createdName=1e1e9780m37(暂无匿称), createdTime=Thu Oct 07 20:08:15 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192132, encodeId=cd971192132ad, content=偏重的研究方向：神经系统疾病;Genetics 经验分享：多活动手脚, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=296a6497387, createdName=ms2000001939126778, createdTime=Fri Feb 11 00:26:21 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188425, encodeId=ec3e1188425ae, content=12月22号投稿，1月26号被拒，中间没有任何状态变化。 拒稿信如下，一同拒绝了我转投他家其他杂志。 If you had approved a lateral transfer to one of the other Neurology Journals (Neurology: Clinical Practice, Neurology: Genetics, or Neurology: Neuroimmunology & Neuroinflammation) the decision to reject also applies to these other journals. 投的生信方面的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=854, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a1de5106745, createdName=146070f9m77(暂无昵称), createdTime=Wed Jan 26 22:16:32 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181053, encodeId=a3f3118105365, content=2021年11月2日投稿，2021年12月7日收到送外审邮件，目前还在under review中！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1295, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=63101979945, createdName=美景, createdTime=Wed Jan 05 21:29:54 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095455, encodeId=5127109545591, content=文章题目有没有撰写模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095456, encodeId=18d51095456a4, content=什么样的题目能让审稿人眼前一亮？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=977, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601459, encodeId=60d060145923, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：Cognitive impairment 经验分享：硕士二年级，Lancet neurology投稿拒稿后转投neurology，审稿一个月后，三个审稿人一直positive，前两个提个两个不算问题的意见，第三个直接说没问题，杂志给的小修，稍微update了一下数据投出后13天直接接收。个人觉得审稿时间在10分以下算很快的了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30a72473112, createdName=肥肥猫目标发lancet, createdTime=Fri Jun 05 01:49:19 CST 2020, time=2020-06-05, status=1, ipAttribution=)]

2022-01-29 ms1000001317492201

投稿一个月后送外审，外审一个半月被拒

1110 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1190321, encodeId=f08a1190321a8, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：genetics;neurology 经验分享：来来回回半年，最后accept了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1413, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Sat Feb 05 14:56:21 CST 2022, time=2022-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953361, encodeId=831e9533619d, content=审稿速度:1.0 偏重的研究方向：AD 经验分享：速度很快，正常大修，不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=946, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=229a5412742, createdName=nmbwcnm, createdTime=Fri Apr 02 19:49:10 CST 2021, time=2021-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189031, encodeId=0aad11890319a, content=投稿一个月后送外审，外审一个半月被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1110, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acb95582948, createdName=ms1000001317492201, createdTime=Sat Jan 29 09:31:48 CST 2022, time=2022-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058443, encodeId=970d105844349, content=偏重的研究方向：神经病理 经验分享：投了一个神经罕见疾病病理方面的稿子，等待中........., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=909, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200528/5dca394cc76f4f16aef355c4dc927622/f9d77939380002a9e1bf3cc072db4be6_1_3_photo.jpg, createdBy=23ff2009942, createdName=1e1e9780m37(暂无匿称), createdTime=Thu Oct 07 20:08:15 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192132, encodeId=cd971192132ad, content=偏重的研究方向：神经系统疾病;Genetics 经验分享：多活动手脚, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=296a6497387, createdName=ms2000001939126778, createdTime=Fri Feb 11 00:26:21 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188425, encodeId=ec3e1188425ae, content=12月22号投稿，1月26号被拒，中间没有任何状态变化。 拒稿信如下，一同拒绝了我转投他家其他杂志。 If you had approved a lateral transfer to one of the other Neurology Journals (Neurology: Clinical Practice, Neurology: Genetics, or Neurology: Neuroimmunology & Neuroinflammation) the decision to reject also applies to these other journals. 投的生信方面的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=854, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a1de5106745, createdName=146070f9m77(暂无昵称), createdTime=Wed Jan 26 22:16:32 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181053, encodeId=a3f3118105365, content=2021年11月2日投稿，2021年12月7日收到送外审邮件，目前还在under review中！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1295, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=63101979945, createdName=美景, createdTime=Wed Jan 05 21:29:54 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095455, encodeId=5127109545591, content=文章题目有没有撰写模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095456, encodeId=18d51095456a4, content=什么样的题目能让审稿人眼前一亮？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=977, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601459, encodeId=60d060145923, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：Cognitive impairment 经验分享：硕士二年级，Lancet neurology投稿拒稿后转投neurology，审稿一个月后，三个审稿人一直positive，前两个提个两个不算问题的意见，第三个直接说没问题，杂志给的小修，稍微update了一下数据投出后13天直接接收。个人觉得审稿时间在10分以下算很快的了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30a72473112, createdName=肥肥猫目标发lancet, createdTime=Fri Jun 05 01:49:19 CST 2020, time=2020-06-05, status=1, ipAttribution=)]

2021-10-07 1e1e9780m37(暂无匿称)

偏重的研究方向：神经病理
经验分享：投了一个神经罕见疾病病理方面的稿子，等待中.........

909 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=1190321, encodeId=f08a1190321a8, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：genetics;neurology 经验分享：来来回回半年，最后accept了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1413, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Sat Feb 05 14:56:21 CST 2022, time=2022-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953361, encodeId=831e9533619d, content=审稿速度:1.0 偏重的研究方向：AD 经验分享：速度很快，正常大修，不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=946, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=229a5412742, createdName=nmbwcnm, createdTime=Fri Apr 02 19:49:10 CST 2021, time=2021-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189031, encodeId=0aad11890319a, content=投稿一个月后送外审，外审一个半月被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1110, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acb95582948, createdName=ms1000001317492201, createdTime=Sat Jan 29 09:31:48 CST 2022, time=2022-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058443, encodeId=970d105844349, content=偏重的研究方向：神经病理 经验分享：投了一个神经罕见疾病病理方面的稿子，等待中........., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=909, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200528/5dca394cc76f4f16aef355c4dc927622/f9d77939380002a9e1bf3cc072db4be6_1_3_photo.jpg, createdBy=23ff2009942, createdName=1e1e9780m37(暂无匿称), createdTime=Thu Oct 07 20:08:15 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192132, encodeId=cd971192132ad, content=偏重的研究方向：神经系统疾病;Genetics 经验分享：多活动手脚, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=296a6497387, createdName=ms2000001939126778, createdTime=Fri Feb 11 00:26:21 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188425, encodeId=ec3e1188425ae, content=12月22号投稿，1月26号被拒，中间没有任何状态变化。 拒稿信如下，一同拒绝了我转投他家其他杂志。 If you had approved a lateral transfer to one of the other Neurology Journals (Neurology: Clinical Practice, Neurology: Genetics, or Neurology: Neuroimmunology & Neuroinflammation) the decision to reject also applies to these other journals. 投的生信方面的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=854, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a1de5106745, createdName=146070f9m77(暂无昵称), createdTime=Wed Jan 26 22:16:32 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181053, encodeId=a3f3118105365, content=2021年11月2日投稿，2021年12月7日收到送外审邮件，目前还在under review中！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1295, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=63101979945, createdName=美景, createdTime=Wed Jan 05 21:29:54 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095455, encodeId=5127109545591, content=文章题目有没有撰写模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095456, encodeId=18d51095456a4, content=什么样的题目能让审稿人眼前一亮？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=977, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601459, encodeId=60d060145923, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：Cognitive impairment 经验分享：硕士二年级，Lancet neurology投稿拒稿后转投neurology，审稿一个月后，三个审稿人一直positive，前两个提个两个不算问题的意见，第三个直接说没问题，杂志给的小修，稍微update了一下数据投出后13天直接接收。个人觉得审稿时间在10分以下算很快的了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30a72473112, createdName=肥肥猫目标发lancet, createdTime=Fri Jun 05 01:49:19 CST 2020, time=2020-06-05, status=1, ipAttribution=)]

2022-02-11 ms2000001939126778

偏重的研究方向：神经系统疾病;Genetics
经验分享：多活动手脚

1165 0

[GetPortalCommentsPageByObjectIdResponse(id=1190321, encodeId=f08a1190321a8, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：genetics;neurology 经验分享：来来回回半年，最后accept了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1413, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Sat Feb 05 14:56:21 CST 2022, time=2022-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953361, encodeId=831e9533619d, content=审稿速度:1.0 偏重的研究方向：AD 经验分享：速度很快，正常大修，不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=946, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=229a5412742, createdName=nmbwcnm, createdTime=Fri Apr 02 19:49:10 CST 2021, time=2021-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189031, encodeId=0aad11890319a, content=投稿一个月后送外审，外审一个半月被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1110, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acb95582948, createdName=ms1000001317492201, createdTime=Sat Jan 29 09:31:48 CST 2022, time=2022-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058443, encodeId=970d105844349, content=偏重的研究方向：神经病理 经验分享：投了一个神经罕见疾病病理方面的稿子，等待中........., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=909, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200528/5dca394cc76f4f16aef355c4dc927622/f9d77939380002a9e1bf3cc072db4be6_1_3_photo.jpg, createdBy=23ff2009942, createdName=1e1e9780m37(暂无匿称), createdTime=Thu Oct 07 20:08:15 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192132, encodeId=cd971192132ad, content=偏重的研究方向：神经系统疾病;Genetics 经验分享：多活动手脚, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=296a6497387, createdName=ms2000001939126778, createdTime=Fri Feb 11 00:26:21 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188425, encodeId=ec3e1188425ae, content=12月22号投稿，1月26号被拒，中间没有任何状态变化。 拒稿信如下，一同拒绝了我转投他家其他杂志。 If you had approved a lateral transfer to one of the other Neurology Journals (Neurology: Clinical Practice, Neurology: Genetics, or Neurology: Neuroimmunology & Neuroinflammation) the decision to reject also applies to these other journals. 投的生信方面的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=854, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a1de5106745, createdName=146070f9m77(暂无昵称), createdTime=Wed Jan 26 22:16:32 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181053, encodeId=a3f3118105365, content=2021年11月2日投稿，2021年12月7日收到送外审邮件，目前还在under review中！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1295, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=63101979945, createdName=美景, createdTime=Wed Jan 05 21:29:54 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095455, encodeId=5127109545591, content=文章题目有没有撰写模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095456, encodeId=18d51095456a4, content=什么样的题目能让审稿人眼前一亮？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=977, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601459, encodeId=60d060145923, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：Cognitive impairment 经验分享：硕士二年级，Lancet neurology投稿拒稿后转投neurology，审稿一个月后，三个审稿人一直positive，前两个提个两个不算问题的意见，第三个直接说没问题，杂志给的小修，稍微update了一下数据投出后13天直接接收。个人觉得审稿时间在10分以下算很快的了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30a72473112, createdName=肥肥猫目标发lancet, createdTime=Fri Jun 05 01:49:19 CST 2020, time=2020-06-05, status=1, ipAttribution=)]

2022-01-26 146070f9m77(暂无昵称)

12月22号投稿，1月26号被拒，中间没有任何状态变化。
拒稿信如下，一同拒绝了我转投他家其他杂志。
If you had approved a lateral transfer to one of the other Neurology Journals (Neurology: Clinical Practice, Neurology: Genetics, or Neurology: Neuroimmunology & Neuroinflammation) the decision to reject also applies to these other journals.
投的生信方面的文章

854 0

[GetPortalCommentsPageByObjectIdResponse(id=1190321, encodeId=f08a1190321a8, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：genetics;neurology 经验分享：来来回回半年，最后accept了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1413, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Sat Feb 05 14:56:21 CST 2022, time=2022-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953361, encodeId=831e9533619d, content=审稿速度:1.0 偏重的研究方向：AD 经验分享：速度很快，正常大修，不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=946, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=229a5412742, createdName=nmbwcnm, createdTime=Fri Apr 02 19:49:10 CST 2021, time=2021-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189031, encodeId=0aad11890319a, content=投稿一个月后送外审，外审一个半月被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1110, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acb95582948, createdName=ms1000001317492201, createdTime=Sat Jan 29 09:31:48 CST 2022, time=2022-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058443, encodeId=970d105844349, content=偏重的研究方向：神经病理 经验分享：投了一个神经罕见疾病病理方面的稿子，等待中........., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=909, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200528/5dca394cc76f4f16aef355c4dc927622/f9d77939380002a9e1bf3cc072db4be6_1_3_photo.jpg, createdBy=23ff2009942, createdName=1e1e9780m37(暂无匿称), createdTime=Thu Oct 07 20:08:15 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192132, encodeId=cd971192132ad, content=偏重的研究方向：神经系统疾病;Genetics 经验分享：多活动手脚, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=296a6497387, createdName=ms2000001939126778, createdTime=Fri Feb 11 00:26:21 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188425, encodeId=ec3e1188425ae, content=12月22号投稿，1月26号被拒，中间没有任何状态变化。 拒稿信如下，一同拒绝了我转投他家其他杂志。 If you had approved a lateral transfer to one of the other Neurology Journals (Neurology: Clinical Practice, Neurology: Genetics, or Neurology: Neuroimmunology & Neuroinflammation) the decision to reject also applies to these other journals. 投的生信方面的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=854, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a1de5106745, createdName=146070f9m77(暂无昵称), createdTime=Wed Jan 26 22:16:32 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181053, encodeId=a3f3118105365, content=2021年11月2日投稿，2021年12月7日收到送外审邮件，目前还在under review中！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1295, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=63101979945, createdName=美景, createdTime=Wed Jan 05 21:29:54 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095455, encodeId=5127109545591, content=文章题目有没有撰写模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095456, encodeId=18d51095456a4, content=什么样的题目能让审稿人眼前一亮？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=977, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601459, encodeId=60d060145923, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：Cognitive impairment 经验分享：硕士二年级，Lancet neurology投稿拒稿后转投neurology，审稿一个月后，三个审稿人一直positive，前两个提个两个不算问题的意见，第三个直接说没问题，杂志给的小修，稍微update了一下数据投出后13天直接接收。个人觉得审稿时间在10分以下算很快的了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30a72473112, createdName=肥肥猫目标发lancet, createdTime=Fri Jun 05 01:49:19 CST 2020, time=2020-06-05, status=1, ipAttribution=)]

2022-01-05 美景

2021年11月2日投稿，2021年12月7日收到送外审邮件，目前还在under review中！

1295 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1190321, encodeId=f08a1190321a8, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：genetics;neurology 经验分享：来来回回半年，最后accept了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1413, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Sat Feb 05 14:56:21 CST 2022, time=2022-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953361, encodeId=831e9533619d, content=审稿速度:1.0 偏重的研究方向：AD 经验分享：速度很快，正常大修，不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=946, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=229a5412742, createdName=nmbwcnm, createdTime=Fri Apr 02 19:49:10 CST 2021, time=2021-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189031, encodeId=0aad11890319a, content=投稿一个月后送外审，外审一个半月被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1110, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acb95582948, createdName=ms1000001317492201, createdTime=Sat Jan 29 09:31:48 CST 2022, time=2022-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058443, encodeId=970d105844349, content=偏重的研究方向：神经病理 经验分享：投了一个神经罕见疾病病理方面的稿子，等待中........., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=909, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200528/5dca394cc76f4f16aef355c4dc927622/f9d77939380002a9e1bf3cc072db4be6_1_3_photo.jpg, createdBy=23ff2009942, createdName=1e1e9780m37(暂无匿称), createdTime=Thu Oct 07 20:08:15 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192132, encodeId=cd971192132ad, content=偏重的研究方向：神经系统疾病;Genetics 经验分享：多活动手脚, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=296a6497387, createdName=ms2000001939126778, createdTime=Fri Feb 11 00:26:21 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188425, encodeId=ec3e1188425ae, content=12月22号投稿，1月26号被拒，中间没有任何状态变化。 拒稿信如下，一同拒绝了我转投他家其他杂志。 If you had approved a lateral transfer to one of the other Neurology Journals (Neurology: Clinical Practice, Neurology: Genetics, or Neurology: Neuroimmunology & Neuroinflammation) the decision to reject also applies to these other journals. 投的生信方面的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=854, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a1de5106745, createdName=146070f9m77(暂无昵称), createdTime=Wed Jan 26 22:16:32 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181053, encodeId=a3f3118105365, content=2021年11月2日投稿，2021年12月7日收到送外审邮件，目前还在under review中！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1295, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=63101979945, createdName=美景, createdTime=Wed Jan 05 21:29:54 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095455, encodeId=5127109545591, content=文章题目有没有撰写模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095456, encodeId=18d51095456a4, content=什么样的题目能让审稿人眼前一亮？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=977, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601459, encodeId=60d060145923, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：Cognitive impairment 经验分享：硕士二年级，Lancet neurology投稿拒稿后转投neurology，审稿一个月后，三个审稿人一直positive，前两个提个两个不算问题的意见，第三个直接说没问题，杂志给的小修，稍微update了一下数据投出后13天直接接收。个人觉得审稿时间在10分以下算很快的了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30a72473112, createdName=肥肥猫目标发lancet, createdTime=Fri Jun 05 01:49:19 CST 2020, time=2020-06-05, status=1, ipAttribution=)]

2021-12-28 Mia

文章题目有没有撰写模板？

0 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1190321, encodeId=f08a1190321a8, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：genetics;neurology 经验分享：来来回回半年，最后accept了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1413, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Sat Feb 05 14:56:21 CST 2022, time=2022-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953361, encodeId=831e9533619d, content=审稿速度:1.0 偏重的研究方向：AD 经验分享：速度很快，正常大修，不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=946, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=229a5412742, createdName=nmbwcnm, createdTime=Fri Apr 02 19:49:10 CST 2021, time=2021-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189031, encodeId=0aad11890319a, content=投稿一个月后送外审，外审一个半月被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1110, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acb95582948, createdName=ms1000001317492201, createdTime=Sat Jan 29 09:31:48 CST 2022, time=2022-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058443, encodeId=970d105844349, content=偏重的研究方向：神经病理 经验分享：投了一个神经罕见疾病病理方面的稿子，等待中........., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=909, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200528/5dca394cc76f4f16aef355c4dc927622/f9d77939380002a9e1bf3cc072db4be6_1_3_photo.jpg, createdBy=23ff2009942, createdName=1e1e9780m37(暂无匿称), createdTime=Thu Oct 07 20:08:15 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192132, encodeId=cd971192132ad, content=偏重的研究方向：神经系统疾病;Genetics 经验分享：多活动手脚, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=296a6497387, createdName=ms2000001939126778, createdTime=Fri Feb 11 00:26:21 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188425, encodeId=ec3e1188425ae, content=12月22号投稿，1月26号被拒，中间没有任何状态变化。 拒稿信如下，一同拒绝了我转投他家其他杂志。 If you had approved a lateral transfer to one of the other Neurology Journals (Neurology: Clinical Practice, Neurology: Genetics, or Neurology: Neuroimmunology & Neuroinflammation) the decision to reject also applies to these other journals. 投的生信方面的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=854, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a1de5106745, createdName=146070f9m77(暂无昵称), createdTime=Wed Jan 26 22:16:32 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181053, encodeId=a3f3118105365, content=2021年11月2日投稿，2021年12月7日收到送外审邮件，目前还在under review中！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1295, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=63101979945, createdName=美景, createdTime=Wed Jan 05 21:29:54 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095455, encodeId=5127109545591, content=文章题目有没有撰写模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095456, encodeId=18d51095456a4, content=什么样的题目能让审稿人眼前一亮？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=977, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601459, encodeId=60d060145923, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：Cognitive impairment 经验分享：硕士二年级，Lancet neurology投稿拒稿后转投neurology，审稿一个月后，三个审稿人一直positive，前两个提个两个不算问题的意见，第三个直接说没问题，杂志给的小修，稍微update了一下数据投出后13天直接接收。个人觉得审稿时间在10分以下算很快的了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30a72473112, createdName=肥肥猫目标发lancet, createdTime=Fri Jun 05 01:49:19 CST 2020, time=2020-06-05, status=1, ipAttribution=)]

2021-12-27 小动量

什么样的题目能让审稿人眼前一亮？

977 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1190321, encodeId=f08a1190321a8, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：genetics;neurology 经验分享：来来回回半年，最后accept了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1413, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f61f2572688, createdName=12588598m48暂无昵称, createdTime=Sat Feb 05 14:56:21 CST 2022, time=2022-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953361, encodeId=831e9533619d, content=审稿速度:1.0 偏重的研究方向：AD 经验分享：速度很快，正常大修，不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=946, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=229a5412742, createdName=nmbwcnm, createdTime=Fri Apr 02 19:49:10 CST 2021, time=2021-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189031, encodeId=0aad11890319a, content=投稿一个月后送外审，外审一个半月被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1110, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acb95582948, createdName=ms1000001317492201, createdTime=Sat Jan 29 09:31:48 CST 2022, time=2022-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058443, encodeId=970d105844349, content=偏重的研究方向：神经病理 经验分享：投了一个神经罕见疾病病理方面的稿子，等待中........., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=909, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200528/5dca394cc76f4f16aef355c4dc927622/f9d77939380002a9e1bf3cc072db4be6_1_3_photo.jpg, createdBy=23ff2009942, createdName=1e1e9780m37(暂无匿称), createdTime=Thu Oct 07 20:08:15 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192132, encodeId=cd971192132ad, content=偏重的研究方向：神经系统疾病;Genetics 经验分享：多活动手脚, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=296a6497387, createdName=ms2000001939126778, createdTime=Fri Feb 11 00:26:21 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188425, encodeId=ec3e1188425ae, content=12月22号投稿，1月26号被拒，中间没有任何状态变化。 拒稿信如下，一同拒绝了我转投他家其他杂志。 If you had approved a lateral transfer to one of the other Neurology Journals (Neurology: Clinical Practice, Neurology: Genetics, or Neurology: Neuroimmunology & Neuroinflammation) the decision to reject also applies to these other journals. 投的生信方面的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=854, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a1de5106745, createdName=146070f9m77(暂无昵称), createdTime=Wed Jan 26 22:16:32 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181053, encodeId=a3f3118105365, content=2021年11月2日投稿，2021年12月7日收到送外审邮件，目前还在under review中！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1295, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=63101979945, createdName=美景, createdTime=Wed Jan 05 21:29:54 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095455, encodeId=5127109545591, content=文章题目有没有撰写模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095456, encodeId=18d51095456a4, content=什么样的题目能让审稿人眼前一亮？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=977, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601459, encodeId=60d060145923, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：Cognitive impairment 经验分享：硕士二年级，Lancet neurology投稿拒稿后转投neurology，审稿一个月后，三个审稿人一直positive，前两个提个两个不算问题的意见，第三个直接说没问题，杂志给的小修，稍微update了一下数据投出后13天直接接收。个人觉得审稿时间在10分以下算很快的了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30a72473112, createdName=肥肥猫目标发lancet, createdTime=Fri Jun 05 01:49:19 CST 2020, time=2020-06-05, status=1, ipAttribution=)]

2020-06-05 肥肥猫目标发lancet

审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：Cognitive impairment
经验分享：硕士二年级，Lancet neurology投稿拒稿后转投neurology，审稿一个月后，三个审稿人一直positive，前两个提个两个不算问题的意见，第三个直接说没问题，杂志给的小修，稍微update了一下数据投出后13天直接接收。个人觉得审稿时间在10分以下算很快的了

317 3

展开3条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务